Notice
Social inequalities impacts of care management and survival in patients with non-hodgkin lymphomas
- document 1 document 2 document 3
- niveau 1 niveau 2 niveau 3
Descriptif
Epidemiologyand public health
The principal aim of thisthesis will describe the care pathway of diffuse large B cell lymphoma (DBCL)and follicular lymphoma (FL) in the general population and identify the factorspredicting the place of care and survival in a population based cohort of nonHodgkin lymphoma (NHL) patients from three counties in France between 2002 and2008. The specific aims will 1/ identify the socioeconomicand medical factors predicting the place of care (teaching vs. non teachinghospitals) and 5 years survival, 2/ identify the socioeconomic andmedical factors predicting longest delays of care and to study theinfluence of longest delays on survival 3/ analyse all thesefactors on a frailty population defined by a high age and/or other criteria ofvulnerability (such as comorbidity).
To answer these questions, the followings methods are proposed:
1/ case registration of all identified NHL (DLBCL and FL) by threehaematological malignancies registries in France (Côte d’Or, Basse Normandieand Gironde). 1977 patients are included. Individual medical data (e.g. patientcharacteristics, management and treatment) from NHL incident cases diagnosedbetween 2002 and 2008 was stored in a standardized database. 2/ we collectedand geocoded the patient’s place of residence at diagnosis. Each patient wasaffected to an IRIS (smallest area allowing for aggregate statistics) using ageographical information system. 3/ we applied successively Townsenddeprivation index and then the new French deprivation index available in 2012in univariate and multivariate analyses. 4/ we used adjusted multilevellogistic regression models to take into account the existence of aggregatedata. The overall survival probability at 1, 3 and 5 years were estimated bythe Kaplan Meier method and then Cox regression model for multivariateanalysis. Net survival (Pohar Perme) and Relative survival (Esteve’s method)was also being performed. Finally, to palliate to a non-negligible proportion of missing values on important prognosticfactors, we used Multiple imputation by Chained Equation (MICE) method.
We will present results of analysis of theinfluence of socio-geographical, medical determinants and treatment provider onrelative survival of DBCL patients.
Cette présentation a été donnée dans le cadre du BRIO SIRICscientific day 3 organisé annuellement par le SIRIC BRIO et qui a pour but deréunir tous les acteurs du SIRIC BRIO et plus largement de la cancérologie àBordeaux.
Thème
Dans la même collection
-
Experts panel discussion: What opportunities and best practices for the use of clinical material in…
CameronDavidEn point d'orgue du Scientific BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur à l'Université d'Edimbourg, anime un débat sur la question des opportinités et bonnes pratiques
-
A new weapon against the tobacco industry : class action lawsuit using a novel epidemiologic param…
SiemiatyckiJackEpidemiology and public health Lawsuits against the tobacco industry, if successful, have the potential to compensate victims of smoking and to diminish the capacity of the tobacco industry to
-
A combined laser microdissection and mass spectrometry method for proteomic analysis of tissue sect…
RaymondAnne-AurélieClinical and biological samples : opportunities and challenges for translational research A challenge in oncology is to better define the tumor of the patient to study the pathology and of course
-
Flash talk - Call for proposal FAC 2014
ElustondoFrédéricWodrichHaraldFaustinBenjaminSaltelFrédéricCognetLaurentPersonalized breast cancer therapy based on viral functional assays to score pathway activity Harald Wodrich, University of Bordeaux State-of-the-art mass sequencing technology has paved the road
-
-
How studying hematological malignancies subtypes may inform epidemiologic and clinical research
MonnereauAlainEpidemiology and public health The aim of the talk entitled "How studying hematological malignancies (HM) subtypes may inform epidemiologic and clinical research" is to bring to the audience
-
BRIO supporting action to integrated cancer research in Bordeaux
MeoniPaoloAbout BRIO Siric challenges and actions The success of BRIO’s approach and the realization of its potential impact on the translational research community in Bordeaux rely both on the efficient
-
-
Sarcoma Database: a unique tool for research on mesenchymal tumors
CoindreJean-MichelClinical biology session The main sarcoma databases are the Conticabase (https://conticabase.sarcomabcb.org) and the ConticaGist (https://conticagist.sarcomabcb.org) with 18000 patients and which
-
Modelling prognostic capabilities of tumor size : application to colorectal cancer
RondeauVirginieEpidemiology and public health In oncology, the international WHO and RECIST criteria have allowed the standardization of tumor response evaluation in order to identify the time of disease
-
BRIO strategic challenges and the implementation of a translational culture in Bordeaux
SoubeyranPierreAbout BRIO Siric challenges and actions BRIO’s strategic objective is to strengthen Bordeaux’s leadership in Cancer Research through the creation of a dynamic cancer research community, the
Sur le même thème
-
Place du brevet dans la recherche d'un laboratoire
DutreixMarieGirardPierre-MarieInterview : la place du brevet dans la recherche d'un laboratoire par Marie Dutreix, directrice de recherche à l'institut Curie.
-
Influence des comportements de santé sur le jugement des femmes consommatrices et atteintes de canc…
AuriolCamilleLes doctorants des universités de Toulouse (UT1C/UT2J/UT3) et de l'Université de Québec à Montréal (UQAM) ont organisé un séminaire de présentation et d'échanges autour de leurs travaux de recherche,
-
[FAB.ISS] Session #5 La fabrique des inégalités sociales de santé et cancer(s)
NicaiseSarahMayèreAnneTerralPhilippeGaboritEmilieDefossezAdrienBartheJean-FrançoisSymposium International FAB.ISS - Ce symposium proposé en 2020 en visioconférence s'intéresse à la fabrique des inégalités sociales de santé, du point de vue des disciplines de sciences humaines et
-
Explorer les impensés de dispositifs de télé-surveillance sur les patient.e.s et leurs modes de vie
MayèreAnneLa conférence du Pr. Anne Mayère (CERTOP, IFERISS, Université de Toulouse, France) est organisée dans le cadre du séminaire télésanté de la Chaire de recherche en francophonie internationale sur les
-
Les jeudis du Grhapes : « Approches sociologiques de l'inclusion », Claude-Julie Bourque, sociolog…
« Approches sociologiques de l'inclusion » Guérir, et puis après... ? Claude-Julie Bourque, sociologue, professeure-chercheure adjointe au département de pédiatrie de la Faculté de médecine de
-
SFjRO Rouen 2019 - Association therapie systémique et radiothérapie
Association therapie systémique et radiothérapie
-
SFjRO Rouen 2019 - Bases physiques et biologie de la proton thérapie
Bases physiques et biologie de la proton thérapie
-
SFjRO Rouen 2019 - Radiosensibilité et apoptose lymphocytaire
Radiosensibilité et apoptose lymphocytaire
-
SFjRO Rouen 2019 - Applications cliniques de la protons thérapie
Applications cliniques de la protons thérapie
-
SFjRO Montpellier 2019 - Radio-hormonothérapie
SFjRO Montpellier 2019 - Radio-hormonothérapie
-
-
SFjRO Montpellier 2019 - Hypofractionnement
SFjRO Montpellier 2019 - Hypofractionnement